Fortive Corporation (FTV) 10-Year Financial Performance & Capital Metrics

FTV • • Industrial / General

TechnologyTech Hardware & EquipmentTest & Measurement EquipmentElectronic Test Equipment

AboutFortive Corporation designs, develops, manufactures, markets, and services professional and engineered products, software, and services worldwide. Its Intelligent Operating Solutions segment offers connected reliability tools; environment, health, safety, and quality enterprise software products; facility and asset lifecycle software; pre-construction planning and construction procurement solutions; ruggedized professional test tools; electric, pressure, and temperature calibration tools; and portable gas detection tools for a range of vertical end markets including manufacturing, process industries, healthcare, utilities and power, communications and electronics, and others. It markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brands. The company's Precision Technologies segment provides electrical test and measurement instruments and services; energetic material devices; and sensor and control system solutions for power and energy, medical equipment, food and beverage, aerospace and defense, off-highway vehicles, electronics, semiconductors, and other general industrial markets. This segment markets its products under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brands. Its Advanced Healthcare Solutions segment offers hardware and software products and services, including instrument and device reprocessing, instrument tracking, biomedical test tools, radiation safety monitoring, and asset management services; subscription-based surgical inventory management systems to facilitate inventory management and regulatory compliance, as well as technical, analytical, and compliance services to determine radiation exposure services under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, RAYSAFE, and STERRAD brands. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.Show more

Revenue $6.23B +2.7%
EBITDA $1.72B +8.2%
Net Income $833M -3.8%
EPS (Diluted) 2.36 -2.9%
Gross Margin 59.87% +1.0%
EBITDA Margin 27.61% +5.3%
Operating Margin 18.88% +1.0%
Net Margin 13.37% -6.4%
ROE 8.12% -6.2%
ROIC 6.92% +0.3%
Debt/Equity 0.38 +3.0%
Interest Coverage 7.70 -16.1%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓FCF machine: 22.6% free cash flow margin
✓High quality earnings: Operating CF exceeds net income
✓Healthy 5Y average net margin of 17.4%

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-0.17%

5Y6.43%

3Y5.85%

TTM-8.96%

Profit (Net Income) CAGR

10Y-0.59%

5Y2.42%

3Y11.04%

TTM-32.27%

EPS CAGR

10Y-0.81%

5Y1.69%

3Y13.13%

TTM-30.28%

ROCE

10Y Avg10.78%

5Y Avg6.97%

3Y Avg7.88%

Latest7.87%

Peer Comparison

Electronic Test Equipment

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
KEYSKeysight Technologies, Inc.	36.85B	214.50	43.95	7.95%	15.74%	14.4%	3.82%	0.51
TDYTeledyne Technologies Incorporated	26.75B	569.72	33.10	0.61%	14.54%	8.27%	4.14%	0.29
FTVFortive Corporation	17.63B	55.51	23.52	2.75%	10.68%	9.25%	7.98%	0.38

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	6.18B	6.22B	5.76B	6.45B	4.56B	4.63B	5.25B	5.83B	6.07B	6.23B
Revenue Growth %	-0.02%	0.01%	-0.08%	0.12%	-0.29%	0.02%	0.13%	0.11%	0.04%	0.03%
Cost of Goods Sold+	3.18B	3.18B	2.83B	3.13B	2.07B	2.02B	2.24B	2.46B	2.47B	2.5B
COGS % of Revenue	0.51%	0.51%	0.49%	0.48%	0.45%	0.44%	0.43%	0.42%	0.41%	0.4%
Gross Profit+	3B	3.04B	2.92B	3.32B	2.5B	2.62B	3.01B	3.36B	3.59B	3.73B
Gross Margin %	0.49%	0.49%	0.51%	0.52%	0.55%	0.56%	0.57%	0.58%	0.59%	0.6%
Gross Profit Growth %	-0.02%	0.01%	-0.04%	0.14%	-0.25%	0.05%	0.15%	0.12%	0.07%	0.04%
Operating Expenses+	1.71B	1.77B	1.76B	2.14B	1.97B	1.97B	2.18B	2.36B	2.46B	2.55B
OpEx % of Revenue	0.28%	0.28%	0.31%	0.33%	0.43%	0.42%	0.41%	0.4%	0.41%	0.41%
Selling, General & Admin	1.33B	1.39B	1.39B	1.72B	1.65B	1.65B	1.82B	1.96B	2.06B	2.14B
SG&A % of Revenue	0.22%	0.22%	0.24%	0.27%	0.36%	0.36%	0.35%	0.34%	0.34%	0.34%
Research & Development	377.7M	384.8M	369.3M	414.3M	320.3M	320.7M	354.8M	401.5M	397.8M	414M
R&D % of Revenue	0.06%	0.06%	0.06%	0.06%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0
Operating Income+	1.29B	1.27B	1.16B	1.19B	529.3M	650.2M	831.5M	1.01B	1.13B	1.18B
Operating Margin %	0.21%	0.2%	0.2%	0.18%	0.12%	0.14%	0.16%	0.17%	0.19%	0.19%
Operating Income Growth %	0.02%	-0.02%	-0.08%	0.02%	-0.55%	0.23%	0.28%	0.21%	0.13%	0.04%
EBITDA+	1.47B	1.44B	1.32B	1.45B	870.8M	1.03B	1.23B	1.47B	1.59B	1.72B
EBITDA Margin %	0.24%	0.23%	0.23%	0.22%	0.19%	0.22%	0.23%	0.25%	0.26%	0.28%
EBITDA Growth %	0.01%	-0.02%	-0.09%	0.1%	-0.4%	0.19%	0.19%	0.2%	0.08%	0.08%
D&A (Non-Cash Add-back)	176.9M	176.4M	158.3M	260.8M	341.5M	384M	395.5M	465.6M	456.8M	543.9M
EBIT	1.27B	1.25B	1.16B	1.18B	479.3M	1.66B	780.7M	971.8M	1.11B	1.12B
Net Interest Income+	0	-49M	-88.7M	-97M	-142.6M	-148.5M	-103.2M	-98.3M	-123.5M	-152.8M
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	0	49M	88.7M	97M	142.6M	148.5M	103.2M	98.3M	123.5M	152.8M
Other Income/Expense	-24.3M	-71.1M	-88M	-107M	-192.6M	857.5M	-154M	-131.8M	-142.9M	-207.1M
Pretax Income+	1.27B	1.2B	1.07B	1.08B	336.7M	1.51B	677.5M	873.5M	990.8M	969.6M
Pretax Margin %	0.21%	0.19%	0.19%	0.17%	0.07%	0.33%	0.13%	0.15%	0.16%	0.16%
Income Tax+	405.9M	324.7M	189.3M	160.1M	68.6M	55.5M	63.3M	118.3M	125M	136.7M
Effective Tax Rate %	0.68%	0.73%	0.97%	2.7%	2.19%	1.07%	0.9%	0.86%	0.87%	0.86%
Net Income+	863.8M	872.3M	1.04B	2.91B	738.9M	1.61B	608.4M	755.2M	865.8M	832.9M
Net Margin %	0.14%	0.14%	0.18%	0.45%	0.16%	0.35%	0.12%	0.13%	0.14%	0.13%
Net Income Growth %	-0.02%	0.01%	0.2%	1.79%	-0.75%	1.18%	-0.62%	0.24%	0.15%	-0.04%
Net Income (Continuing)	863.8M	872.3M	884.3M	918.3M	268.1M	1.45B	614.2M	755.2M	865.8M	832.9M
Discontinued Operations	0	0	160.2M	2B	470.8M	161.1M	-5.8M	0	0	0
Minority Interest	3M	3.1M	17.9M	17.4M	13.2M	8.5M	4.8M	5.2M	6.4M	7M
EPS (Diluted)+	2.50	2.51	2.96	8.31	2.17	4.30	1.63	2.09	2.43	2.36
EPS Growth %	-0.02%	0%	0.18%	1.81%	-0.74%	0.98%	-0.62%	0.28%	0.16%	-0.03%
EPS (Basic)	2.50	2.52	3.01	8.43	2.20	4.58	1.64	2.12	2.46	2.39
Diluted Shares Outstanding	345.2M	347.3M	352.6M	350.7M	340M	359M	352.3M	360.8M	355.6M	352.8M
Basic Shares Outstanding	345.2M	345.7M	347.5M	345.5M	335.8M	337.4M	349M	356.4M	352.5M	349.2M
Dividend Payout Ratio	-	3.49%	0.09%	0.03%	0.13%	0.06%	0.16%	0.13%	0.12%	0.13%

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	1.59B	2.49B	2.94B	3.17B	3.69B	4.45B	2.51B	2.48B	3.67B	2.59B
Cash & Short-Term Investments	0	803.2M	962.1M	1.18B	1.21B	2.94B	819.3M	709.2M	1.89B	813.3M
Cash Only	0	803.2M	962.1M	1.18B	1.21B	1.82B	819.3M	709.2M	1.89B	813.3M
Short-Term Investments	0	0	0	0	0	1.12B	0	0	0	0
Accounts Receivable	979.3M	945.4M	1.02B	1.2B	890.7M	810.3M	930.2M	958.5M	960.8M	945.4M
Days Sales Outstanding	57.85	55.44	64.71	67.6	71.23	63.82	64.61	60.05	57.82	55.37
Inventory	522.9M	544.6M	580.6M	574.5M	640.3M	455.5M	512.7M	536.7M	536.9M	544.8M
Days Inventory Outstanding	60.06	62.44	74.81	67.01	113.07	82.4	83.36	79.56	79.3	79.52
Other Current Assets	0	0	203.8M	30M	838.1M	30.4M	0	272.6M	285.1M	118M
Total Non-Current Assets+	5.62B	5.7B	7.56B	9.73B	13.75B	11.6B	13.95B	13.41B	13.24B	14.42B
Property, Plant & Equipment	514.8M	547.6M	610.4M	576.1M	585M	610.7M	395.5M	421.9M	439.8M	433.1M
Fixed Asset Turnover	12.00x	11.37x	9.43x	11.20x	7.80x	7.59x	13.29x	13.81x	13.79x	14.39x
Goodwill	3.95B	3.98B	5.1B	6.13B	8.4B	7.36B	9.15B	9.05B	9.12B	10.16B
Intangible Assets	759M	747.3M	1.28B	2.48B	3.85B	3.29B	3.89B	3.49B	3.16B	3.34B
Long-Term Investments	0	0	0	0	0	0	0	0	0	59M
Other Non-Current Assets	393.7M	427.2M	1.14B	548.9M	2.35B	344.1M	512.9M	455.8M	518.9M	435.7M
Total Assets+	7.21B	8.19B	10.5B	12.91B	17.44B	16.05B	16.47B	15.89B	16.91B	17.02B
Asset Turnover	0.86x	0.76x	0.55x	0.50x	0.26x	0.29x	0.32x	0.37x	0.36x	0.37x
Asset Growth %	-0.02%	0.14%	0.28%	0.23%	0.35%	-0.08%	0.03%	-0.03%	0.06%	0.01%
Total Current Liabilities+	1.32B	1.47B	1.6B	2.19B	3.47B	2.86B	3.71B	2.73B	1.79B	2.24B
Accounts Payable	657.1M	666.2M	629M	706.5M	449M	480.8M	557.9M	623M	608.6M	677.4M
Days Payables Outstanding	75.48	76.38	81.05	82.4	79.29	86.98	90.71	92.35	89.89	98.87
Short-Term Debt	0	0	0	455.6M	1.5B	1.4B	2.15B	999.7M	0	376.2M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	303.4M	393.2M	552.1M	435.5M	1.02B	434.4M	399.9M	378.6M	427.3M	407.4M
Current Ratio	1.20x	1.70x	1.83x	1.45x	1.06x	1.55x	0.68x	0.91x	2.05x	1.16x
Quick Ratio	0.81x	1.33x	1.47x	1.18x	0.88x	1.40x	0.54x	0.71x	1.75x	0.91x
Cash Conversion Cycle	42.44	41.5	58.47	52.21	105.02	59.24	57.26	47.26	47.23	36.02
Total Non-Current Liabilities+	704.6M	4.03B	5.09B	4.1B	6.57B	4.22B	3.23B	3.47B	4.8B	4.58B
Long-Term Debt	0	3.36B	4.06B	2.97B	4.83B	2.83B	1.81B	2.25B	3.65B	3.33B
Capital Lease Obligations	0	0	3.4M	0	133.8M	154.3M	139.9M	131M	126.3M	132.8M
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	620.7M	594.2M	947.2M	1.03B	1.58B	1.2B	1.25B	1.05B	976.9M	1.06B
Total Liabilities	2.03B	5.5B	6.69B	6.29B	10.04B	7.08B	6.95B	6.2B	6.59B	6.82B
Total Debt+	0	3.36B	4.06B	3.43B	6.5B	4.43B	4.14B	3.42B	3.81B	3.88B
Net Debt	0	2.55B	3.09B	2.25B	5.3B	2.61B	3.32B	2.71B	1.92B	3.06B
Debt / Equity	-	1.25x	1.07x	0.52x	0.88x	0.49x	0.44x	0.35x	0.37x	0.38x
Debt / EBITDA	-	2.32x	3.07x	2.37x	7.47x	4.28x	3.38x	2.33x	2.40x	2.25x
Net Debt / EBITDA	-	1.77x	2.34x	1.56x	6.08x	2.52x	2.71x	1.84x	1.21x	1.78x
Interest Coverage	-	25.88x	13.10x	12.22x	3.71x	4.38x	8.06x	10.23x	9.18x	7.70x
Total Equity+	5.18B	2.69B	3.81B	6.61B	7.4B	8.97B	9.52B	9.69B	10.33B	10.2B
Equity Growth %	-0.01%	-0.48%	0.42%	0.74%	0.12%	0.21%	0.06%	0.02%	0.07%	-0.01%
Book Value per Share	15.01	7.75	10.80	18.86	21.77	24.99	27.01	26.85	29.04	28.90
Total Shareholders' Equity	5.18B	2.69B	3.79B	6.6B	7.39B	8.96B	9.51B	9.68B	10.32B	10.19B
Common Stock	5.19B	3.5M	3.5M	3.4M	3.4M	3.4M	3.6M	3.6M	3.6M	3.7M
Retained Earnings	0	403M	1.35B	3.55B	4.13B	5.55B	6.02B	6.74B	7.51B	8.23B
Treasury Stock	0	0	0	0	0	0	0	-442.9M	-715.8M	-1.61B
Accumulated OCI	-14.4M	-145.8M	-7.6M	-86.6M	-56.3M	-141.1M	-185M	-325.7M	-326.1M	-465.4M
Minority Interest	3M	3.1M	17.9M	17.4M	13.2M	8.5M	4.8M	5.2M	6.4M	7M

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	1.01B	1.14B	1.18B	1.34B	1.27B	1.44B	961.1M	1.3B	1.35B	1.53B
Operating CF Margin %	0.16%	0.18%	0.2%	0.21%	0.28%	0.31%	0.18%	0.22%	0.22%	0.25%
Operating CF Growth %	0.07%	0.13%	0.03%	0.14%	-0.05%	0.13%	-0.33%	0.36%	0.04%	0.13%
Net Income	863.8M	872.3M	1.04B	918.3M	725.4M	1.45B	614.2M	755.2M	865.8M	832.9M
Depreciation & Amortization	176.9M	176.4M	174.1M	260.8M	426.2M	384M	395.5M	465.6M	456.8M	543.9M
Stock-Based Compensation	35.2M	45.3M	48.6M	50.8M	61.4M	62.6M	77.4M	93.8M	113.3M	109.2M
Deferred Taxes	0	-10M	-78.2M	7.7M	-13.5M	-97.6M	15.4M	-62.1M	-104.1M	-65M
Other Non-Cash Items	12M	14.8M	57.2M	136.5M	-40.8M	-567.9M	-29.9M	71.3M	0	1.9M
Working Capital Changes	-78.9M	38.1M	-69.8M	-29.7M	112.7M	203.4M	-111.5M	-20.6M	21.8M	103.9M
Change in Receivables	-51.8M	24.8M	-65.4M	-105.9M	-166.9M	82.4M	-84.1M	-52.1M	9.8M	-4.5M
Change in Inventory	-27.7M	-28.7M	14.3M	-73.4M	118.8M	-7.3M	-53.6M	-40.3M	-1.7M	8.8M
Change in Payables	53.6M	17.2M	24.9M	76.2M	53.7M	18.1M	73.4M	81.3M	-16.8M	74.3M
Cash from Investing+	-174.1M	-310.8M	-1.67B	-1.97B	-4.05B	-148.4M	-2.62B	-102.5M	-195.4M	-1.8B
Capital Expenditures	-120.1M	-129.6M	-136.1M	-112.3M	-112.5M	-75.7M	-50M	-95.8M	-107.8M	-120.4M
CapEx % of Revenue	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.01%	0.02%	0.02%	0.02%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-16.9M	8.9M	23M	960.8M	1.8M	-32.3M	4.5M	-3.5M	8.2M	46.2M
Cash from Financing+	-834.9M	3.8M	599.7M	879.1M	2.8B	-696.1M	652M	-1.27B	32.3M	-792.7M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	-3.05B	-97.2M	-131.5M	-162.8M	-163.4M	-132.2M	-99.5M	-102M	-111.2M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-834.9M	-299.7M	14.8M	1.12B	13M	1.6B	30.6M	-6.7M	18M	71.1M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	888.9M	1.01B	1.04B	1.23B	1.16B	1.36B	911.1M	1.21B	1.25B	1.41B
FCF Margin %	0.14%	0.16%	0.18%	0.19%	0.25%	0.29%	0.17%	0.21%	0.21%	0.23%
FCF Growth %	0.05%	0.13%	0.03%	0.18%	-0.06%	0.17%	-0.33%	0.33%	0.03%	0.13%
FCF per Share	2.58	2.90	2.95	3.51	3.41	3.79	2.59	3.35	3.50	3.99
FCF Conversion (FCF/Net Income)	1.17x	1.30x	1.13x	0.46x	1.72x	0.89x	1.58x	1.73x	1.56x	1.83x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	16.59%	22.16%	32.14%	55.92%	10.55%	19.71%	6.58%	7.86%	8.65%	8.12%
Return on Invested Capital (ROIC)	18.64%	18.24%	14.34%	11.28%	3.68%	4.02%	5.11%	5.97%	6.9%	6.92%
Gross Margin	48.57%	48.86%	50.79%	51.5%	54.71%	56.46%	57.28%	57.73%	59.26%	59.87%
Net Margin	13.98%	14.01%	18.15%	45.16%	16.19%	34.81%	11.58%	12.96%	14.27%	13.37%
Debt / Equity	-	1.25x	1.07x	0.52x	0.88x	0.49x	0.44x	0.35x	0.37x	0.38x
Interest Coverage	-	25.88x	13.10x	12.22x	3.71x	4.38x	8.06x	10.23x	9.18x	7.70x
FCF Conversion	1.17x	1.30x	1.13x	0.46x	1.72x	0.89x	1.58x	1.73x	1.56x	1.83x
Revenue Growth	-2.5%	0.74%	-7.52%	12.1%	-29.27%	1.54%	13.38%	10.87%	4.11%	2.75%

Revenue by Segment

	2016	2017	2018	2019	2020	2021	2022	2023	2024
Intelligent Operating Solutions	-	-	-	-	1.88B	2.17B	2.47B	2.61B	2.71B
Intelligent Operating Solutions Growth	-	-	-	-	-	15.17%	13.68%	5.92%	3.92%
Precision Technologies	-	-	-	-	1.65B	1.85B	2.04B	2.13B	2.23B
Precision Technologies Growth	-	-	-	-	-	11.97%	10.24%	4.64%	4.53%
Advanced Healthcare Solutions	-	-	-	-	1.1B	1.24B	1.32B	1.32B	1.29B
Advanced Healthcare Solutions Growth	-	-	-	-	-	12.46%	6.87%	-0.08%	-2.47%
Product	-	-	5.75B	6.4B	-	-	-	-	-
Product Growth	-	-	-	11.15%	-	-	-	-	-
Professional Tools and Equipment	4.01B	4.35B	4.99B	5.01B	-	-	-	-	-
Professional Tools and Equipment Growth	-	8.65%	14.64%	0.50%	-	-	-	-	-
Medical Technologies	-	-	-	934.2M	-	-	-	-	-
Medical Technologies Growth	-	-	-	-	-	-	-	-	-
Service	-	-	697.7M	923.1M	-	-	-	-	-
Service Growth	-	-	-	32.31%	-	-	-	-	-
Franchise Distribution	618.1M	626.2M	640M	637.9M	-	-	-	-	-
Franchise Distribution Growth	-	1.31%	2.20%	-0.33%	-	-	-	-	-
Industrial Automation, Controls and Sensors	1.14B	1.21B	541M	484.1M	-	-	-	-	-
Industrial Automation, Controls and Sensors Growth	-	6.11%	-55.20%	-10.52%	-	-	-	-	-
All Other Products and Services	462.1M	469.6M	282M	249.1M	-	-	-	-	-
All Other Products and Services Growth	-	1.62%	-39.95%	-11.67%	-	-	-	-	-

Revenue by Geography

	2016	2017	2018	2019	2020	2021	2022	2023	2024
UNITED STATES	3.47B	3.64B	3.54B	4.21B	2.44B	2.68B	3.14B	3.29B	3.37B
UNITED STATES Growth	-	4.75%	-2.65%	18.84%	-42.08%	10.11%	16.91%	4.83%	2.54%
Countries Excluding United States and China	1.95B	2.1B	2.11B	2.52B	1.66B	1.92B	1.99B	2.08B	2.21B
Countries Excluding United States and China Growth	-	7.75%	0.44%	19.54%	-34.02%	15.47%	3.43%	4.79%	6.22%
CHINA	536M	612.1M	569M	592M	534.1M	650.7M	702.1M	694.9M	648.2M
CHINA Growth	-	14.20%	-7.04%	4.04%	-9.78%	21.83%	7.90%	-1.03%	-6.72%
GERMANY	268.1M	307.7M	234.7M	-	-	-	-	-	-
GERMANY Growth	-	14.77%	-23.72%	-	-	-	-	-	-

Frequently Asked Questions

Valuation & Price

Fortive Corporation (FTV) has a price-to-earnings (P/E) ratio of 23.5x. This is roughly in line with market averages.

Growth & Financials

Fortive Corporation (FTV) reported $5.64B in revenue for fiscal year 2024. This represents a 5% decrease from $5.96B in 2013.

Fortive Corporation (FTV) grew revenue by 2.7% over the past year. Growth has been modest.

Yes, Fortive Corporation (FTV) is profitable, generating $602.3M in net income for fiscal year 2024 (13.4% net margin).

Dividend & Returns

Yes, Fortive Corporation (FTV) pays a dividend with a yield of 0.57%. This makes it attractive for income-focused investors.

Fortive Corporation (FTV) has a return on equity (ROE) of 8.1%. This is below average, suggesting room for improvement.

Fortive Corporation (FTV) generated $1.08B in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...